Literature DB >> 24791846

Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose?

Bogdan S Ungureanu1, Larisa Sandulescu2, Valeriu Şurlin3, Zeno Spârchez4, Adrian Săftoiu2.   

Abstract

Clinical evolution of the colorectal carcinoma occurs in up to 60% with colorectal liver metastases (CRLM). Although hepatic resection is considered to be the golden standard in CRLM, novel less invasive techniques have emerged, of which radiofrequency ablation has received a high credibility. When tumors are not eligible for surgery, guided radiofrequency ablation is considered an alternative. This method is appropriate when there are no more than 5 lesions with a diameter of less than 3 cm. While open surgery guarantees a more precise tumor excision, the effectiveness of ablation must be evaluated either by contrast-enhanced computer tomography, magnetic resonance, or ultrasound. This paper aim to review the current standings in radiofrequency ablation for CRLM and to compare the technique with surgical resection in order to find which one is the best treatment option.

Entities:  

Mesh:

Year:  2014        PMID: 24791846     DOI: 10.11152/mu.201.3.2066.162.bsu1

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  6 in total

Review 1.  Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence.

Authors:  Rafael Diaz-Nieto; Stephen Fenwick; Hassan Malik; Graeme Poston
Journal:  Curr Treat Options Oncol       Date:  2017-02

Review 2.  Surgery for oligometastasis of pancreatic cancer.

Authors:  Fengchun Lu; Katherine E Poruk; Matthew J Weiss
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

3.  Biliary Stenting for Malignant Biliary Obstruction Secondary to Pancreatic Cancer.

Authors:  Alexandru Constantinescu; Vasile Şandru; Madalina Ilie; Bogdan Silviu Ungureanu; Dan IonuŢ Gheonea; Tudorel Ciurea; Sergiu Marian Cazacu; Cristin-Constantin Vere; Gabriel Constantinescu
Journal:  Curr Health Sci J       Date:  2020-12-31

4.  The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate.

Authors:  Hector Guadalajara; Olatz Lopez-Fernandez; Miguel León Arellano; Víctor Domínguez-Prieto; Cristina Caramés; Damian Garcia-Olmo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10

5.  Efficacy of Endobiliary Radiofrequency Ablation in Preserving Survival, Performance Status and Chemotherapy Eligibility of Patients with Unresectable Distal Cholangiocarcinoma: A Case-Control Study.

Authors:  Vasile Sandru; Bogdan Silviu Ungureanu; Madalina Stan-Ilie; Ruxandra Oprita; Gheorghe G Balan; Oana-Mihaela Plotogea; Ecaterina Rinja; Andreea Butuc; Afrodita Panaitescu; Alexandru Constantinescu; Dan Ionut Gheonea; Gabriel Constantinescu
Journal:  Diagnostics (Basel)       Date:  2022-07-26

6.  The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.

Authors:  Byoung Chul Lee; Hyun Gu Lee; In Ja Park; So Yeon Kim; Ki-Hun Kim; Jae Hoon Lee; Chan Wook Kim; Jong Lyul Lee; Yong Sik Yoon; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.